Nanochannel delivery system for CBD: Sustained low level plasma levels without liver toxicity
-
Published:2023-01
Issue:
Volume:79
Page:104029
-
ISSN:1773-2247
-
Container-title:Journal of Drug Delivery Science and Technology
-
language:en
-
Short-container-title:Journal of Drug Delivery Science and Technology
Author:
Kaplan Barbara L.F.ORCID,
Swanson Elizabeth A.ORCID,
Ross Matthew K.ORCID,
Olivier Alicia K.,
Guo-Ross Shirley X.,
Burroughs Kylee J.,
Ross Angela K.,
Matula Michael,
Tarbox TamaraORCID,
Greenberg Mitchell,
Carr Russell L.ORCID
Subject
Pharmaceutical Science
Reference32 articles.
1. Buccally absorbed cannabidiol shows significantly superior pain control and improved satisfaction immediately after arthroscopic rotator cuff repair: a placebo-controlled, double-blinded, randomized trial;Alaia;Am. J. Sports Med.,2022
2. A placebo-controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans;Arout;Br. J. Clin. Pharmacol.,2022
3. The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain;Bebee;Med. J. Aust.,2021
4. Pain response to cannabidiol in opioid-induced hyperalgesia, acute nociceptive pain, and allodynia using a model mimicking acute pain in healthy adults in a randomized trial (CANAB II);Dieterle;Pain,2022
5. Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study;Frane;J. Cannabis Res.,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献